Results 241 to 250 of about 77,126 (266)
Some of the next articles are maybe not open access.

CARDIOGENIC SHOCK

Critical Care Clinics, 2001
Mortality rates in patients with cardiogenic shock remain frustratingly high. Its pathophysiology involves a downward spiral in which ischemia causes myocardial dysfunction, which in turn worsens ischemia. Areas of viable but nonfunctional myocardium can contribute to the development of cardiogenic shock.
openaire   +3 more sources

Cardiogenic Shock

Cardiology Clinics, 2013
Cardiogenic shock (CS) is a condition in which a marked reduction in cardiac output and inadequate end-organ perfusion results from an array of cardiac insults, the most common of which is acute myocardial infarction. CS is a systemic disease involving a vicious cycle of inflammation, ischemia, and progressive myocardial dysfunction, which often ...
Howard A, Cooper, Julio A, Panza
openaire   +2 more sources

Pathophysiology of cardiogenic shock

Current Opinion in Critical Care, 2021
Purpose of review We describe the pathophysiology of cardiogenic shock (CS), from the main pathways to the inflammatory mechanisms and the proteomic features. Recent findings Although the classical pathophysiological pathways underlying CS, namely reduced organ perfusion due to ...
Pietro Bertini, Fabio Guarracino
openaire   +3 more sources

Cardiogenic Shock

Chest, 1983
The definition, pathophysiology, and diagnosis of cardiogenic shock are presented. Its management is detailed, including specific forms of therapy for the various subgroups of patients in whom cardiogenic shock is an integral part. The choice of patients for and results of circulatory support using the intra-aortic balloon pump followed by early ...
openaire   +3 more sources

Cardiogenic Shock

Critical Care Clinics, 2014
Cardiogenic shock is the most common cause of in-hospital mortality for patients who have suffered a myocardial infarction. Mortality exceeds 50% and management is focused on a rapid diagnosis of cardiogenic shock, restoration of coronary blood flow through early revascularization, complication management, and maintenance of end-organ homeostasis ...
Palak, Shah, Jennifer A, Cowger
openaire   +2 more sources

Revascularization in cardiogenic shock

Herz, 2020
Approximately 10% of patients with acute myocardial infarction develop cardiogenic shock. Randomized studies have shown a significant improvement in survival with early revascularization, which now represents the most important cornerstone in the treatment of infarct-related cardiogenic shock.
Anne Freund   +2 more
openaire   +2 more sources

SURGERY FOR CARDIOGENIC SHOCK

The Lancet, 1974
Abstract Eleven patients were consecutively operated upon for cardiogenic shock caused by myocardial infarction. The cardiogenic shock was refractory to conventional medical therapy. All eleven patients were dependent on intra-aortic counterpulsation balloon until after surgery.
M. G. Miller   +4 more
openaire   +4 more sources

Cardiogenic Shock in Women [PDF]

open access: possibleInterventional Cardiology Clinics, 2012
Cardiogenic shock (CS) describes the physiologic state in which reduced cardiac output and resultant tissue hypoxia occur in the presence of adequate intravascular volume. Among patients hospitalized with myocardial infarction (MI), CS is the foremost cause of death.
Roxana Mehran   +4 more
openaire   +2 more sources

Hemodynamics of Cardiogenic Shock

Interventional Cardiology Clinics, 2017
Cardiogenic shock (CS) represents an advanced state of morbidity along the pathophysiologic pathway of end-organ hypoperfusion caused by reduced cardiac output and blood pressure. Acute coronary syndromes remain the most common cause of CS. The spectrum of hypoperfusion states caused by low cardiac output ranges from pre-CS to refractory CS and can be ...
Jeffrey D. Wessler   +2 more
openaire   +3 more sources

Cardiogenic Shock

Critical Care Nursing Clinics of North America, 2011
Cardiogenic shock remains a significant issue and affects 5% to 10% of patients admitted with an AMI. Mortality remains high despite advances in treatment for AMI. These patients are best treated in centers where they can receive treatment that follows the joint guidelines recommended by ACC and AHA.
openaire   +2 more sources

Home - About - Disclaimer - Privacy